Toshio Shinoda

Summary

Publications

  1. doi request reprint Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative study
    Toshio Shinoda
    Dialysis Center, Kawakita General Hospital, Asagaya kita 1 7 3, Tokyo, Japan
    Ther Apher Dial 17:29-34. 2013
  2. doi request reprint Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan
    Toshio Shinoda
    Kawakita General Hospital, Tokyo, Japan
    Contrib Nephrol 168:173-8. 2011
  3. doi request reprint Anticoagulation in acute blood purification for acute renal failure in critical care
    Toshio Shinoda
    Dialysis Center, Kawakita General Hospital, Tokyo, Japan
    Contrib Nephrol 166:119-25. 2010
  4. doi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2008)
    Shigeru Nakai
    Renal Data Registry Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 14:505-40. 2010
  5. doi request reprint An overview of regular dialysis treatment in Japan (as of 31 December 2007)
    Shigeru Nakai
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 13:457-504. 2009
  6. doi request reprint An overview of regular dialysis treatment in Japan (as of 31 December 2010)
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 16:483-521. 2012
  7. doi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2009)
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 16:11-53. 2012
  8. doi request reprint Overview of regular dialysis treatment in Japan as of 31 December 2006
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 12:428-56. 2008
  9. ncbi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2005)
    Shigeru Nakai
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 11:411-41. 2007
  10. ncbi request reprint Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan
    Kunitoshi Iseki
    Patient Registration Committee of Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 11:183-8. 2007

Collaborators

Detail Information

Publications15

  1. doi request reprint Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative study
    Toshio Shinoda
    Dialysis Center, Kawakita General Hospital, Asagaya kita 1 7 3, Tokyo, Japan
    Ther Apher Dial 17:29-34. 2013
    ..The results of this trial suggest that, if dosages of vitamin D and cinacalcet are adequately controlled, a switch to lanthanum carbonate and its concomitant use are effective to control the Ca and P levels without changing iPTH levels...
  2. doi request reprint Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan
    Toshio Shinoda
    Kawakita General Hospital, Tokyo, Japan
    Contrib Nephrol 168:173-8. 2011
    ..Although online hemodiafiltration has potential advantage over high-flux HD, the impact of this therapy has not been evident because of its low prevalence in chronic dialysis therapy in Japan...
  3. doi request reprint Anticoagulation in acute blood purification for acute renal failure in critical care
    Toshio Shinoda
    Dialysis Center, Kawakita General Hospital, Tokyo, Japan
    Contrib Nephrol 166:119-25. 2010
    ..Nafamostat has been widely used in acute blood purification at critical care units in Japan...
  4. doi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2008)
    Shigeru Nakai
    Renal Data Registry Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 14:505-40. 2010
    ..The risk of becoming HCV-positive was high in patients with low serum creatinine, serum albumin, and serum total cholesterol levels, and/or a low body mass index before beginning dialysis...
  5. doi request reprint An overview of regular dialysis treatment in Japan (as of 31 December 2007)
    Shigeru Nakai
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 13:457-504. 2009
    ..The serum creatinine level of patients upon introduction to dialysis was 8.34 (+/-3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (+/-3.43) mL/min/1.73 m(2) for the patients who were newly begun on dialysis in 2007...
  6. doi request reprint An overview of regular dialysis treatment in Japan (as of 31 December 2010)
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 16:483-521. 2012
    ..0%; 2010, 23.2%). A total weekly Kt/V attributable to peritoneal dialysis and their residual functional kidney was 1.7 or higher for 59.4% of patients who underwent peritoneal dialysis...
  7. doi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2009)
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 16:11-53. 2012
    ..e. serum calcium concentration, serum phosphorus concentration, and serum intact parathyroid hormone concentration. According to the questionnaire, 9.8% of the patients were considered to have a complication of dementia...
  8. doi request reprint Overview of regular dialysis treatment in Japan as of 31 December 2006
    Shigeru Nakai
    Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 12:428-56. 2008
    ..37 +/- 3.58 mg/dL. The estimated glomerular filtration rate, which was calculated with formula modified for the Japanese population from the Modification of Diet in Renal Disease (MDRD) Study equation, was 5.46 +/- 6.60 mL/min/1.73 m(2)...
  9. ncbi request reprint Overview of regular dialysis treatment in Japan (as of 31 December 2005)
    Shigeru Nakai
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 11:411-41. 2007
    ..Results showed that the mean life expectancy of the dialysis population was approximately 40-60% of that of the general population of the same sex and age...
  10. ncbi request reprint Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan
    Kunitoshi Iseki
    Patient Registration Committee of Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 11:183-8. 2007
    ..Despite the high prescription rate of antihypertensive drugs, control of blood pressure remains unsatisfactory...
  11. ncbi request reprint Pancreaticoduodenectomy for bile duct carcinoma of a patient undergoing hemodialysis
    Taiichi Otani
    Department of Surgery, Social Insurance Chuou General Hospital, Tokyo, Japan
    Hepatogastroenterology 55:24-6. 2008
    ..The postoperative course was uneventful. We present herein a successful case of pancreaticoduodenectomy for a patient undergoing hemodialysis to maintain the same body weight...
  12. doi request reprint Guidance of technical management of dialysis water and dialysis fluid for the Japan Association for Clinical Engineering Technologists
    Tadayuki Kawasaki
    Working Group for Dialysis Fluid, Blood Purification Standardization Committee, Japan Association for Clinical Engineering Technologists, Tokyo, Japan
    Blood Purif 27:41-9. 2009
    ..They should outline safer dialysis by the management of purification of dialysis fluid...
  13. ncbi request reprint A case report of autoimmune pancreatitis accompanied with rapidly developing hyperglycemia and hypertension in a chronic hemodialysis patient
    Kentaro Wada
    Department of Internal Medicine, Division of Nephrology and Dialysis, Social Insurance Chuo General Hospital, Shinjuku ku, Tokyo, Japan
    Ther Apher Dial 11:150-4. 2007
    ..AIMP is a rare but important complication in HD patients that requires prompt diagnosis and treatment; we are therefore reporting on a unique complication in a chronic HD patient...
  14. pmc Effect of erythropoietin-stimulating agent on uremic inflammation
    Yuri Tanaka
    Division of Nephrology, Toho University Ohashi Medical Center, 2 17 6, Ohashi, Tokyo, Meguro ku, 153 8515, Japan
    J Inflamm (Lond) 9:17. 2012
    ..abstract:..
  15. ncbi request reprint An overview of regular dialysis treatment in Japan (as of 31 December 2004)
    Shigeru Nakai
    Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan
    Ther Apher Dial 10:476-97. 2006
    ..The percentage of patients who received PEIT again was 35.0%. The percentage of patients who had been on hemodialysis for more than 10 years and received PEIT again was more than 50%...